Eden News

Eden was proud to be named ESG Company of the Year at the 2024 Small Cap Network Awards, celebrating its commitment to environmental, social, and governance standards and its role in advancing the green economy. The award reflects Eden’s innovative approach to sustainable agriculture and its status as a leader in sustainability, further endorsed by its Green Economy Mark from the London Stock Exchange.  

For more information, follow this link. 

Californian state authorities have granted regulatory approval for Eden's biofungidcide Mevalone® for use on grapes to tackle botrytis cinerea. This regulatory approval is a key breakthrough for the company considering California stands as the US' largest wine-producing state, synonymous with famous regions such as Napa Valley, Sonoma Valley and Monterey.This development follows regulatory approval from the United States Environmental Protection Agency (EPA) in September 2022 for all five petitions submitted by Eden.

For more information, follow this link.

Ecovelex has been granted temporary authorisation by the Italian authorities for farmers to use the production on corn for the 2024 growing season. This is the first time that Eden's sustainable seed treatment has been made commercially available.  

For more information, follow this link. 

A first order has been placed for Ecovelex®, representing a landmark moment for the company and maize growers alike. Production is now underway in the UK, and it is expected that shipment will be made by the end of the year. This first order follows the company's successful fundraise completed in August 2023.

For more information, follow this link. 

Partnering with ANASAC, Eden will be looking to bring Mevalone to the Colombian cut flower market to prevent and treat outbreaks of Botrytis cinerea in ornamental crops. ANASAC's appointment as the Company's exclusive distribution partner in the region precedes a regulatory application to allow the specific use of Eden’s biofungicide product on cut flowers and other ornamental crops. Colombia is the world's second-largest exporter of cut flowers, and the market represents the nation's 6th largest export, with the US importing approximately $1.35 billion of the product annually. 

For further information, follow this link here.

In close partnership with Corteva Agriscience, Eden Research has unveiled a new seed treatment - Ecovelex™. The product has been developed to tackle crop destruction caused by birds - a major cause of losses in maize and other crops.  Ecovelex works by affecting the bird's olfactory system, creating an unpleasant taste or odour that repels the birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. 

Eden has applied for the authorization of Ecovelex in the EU, with an application in the UK to follow, with Corteva Agriscience as its distribution partner. For more information, follow this link.

Eden's flagship biofungicide as been granted regulatory approval for commercial use on wine and table grapes, targeting outbreaks of Botrytis cinerea (Botrytis). The product will be marketed as Novellus® in the region. Sipcam Oxon SpA has been appointed as the Company's exclusive distributor of Novellus locally, with product distribution expected to commence in time for its 2023/24 growing season.

For further information, follow this link here.

Mevalone® and Cedroz™ are now authorised for sale and will be applied to various crops across Florida following regulatory clearance by the state authorities. Cedroz has also been approved in California, and we eagerly await Mevalone approval which is expected in due course.

For further information, follow this link here.

Mevalone® has been granted regulatory approval for use in Poland. The certification will allow farmers to apply Mevalone to their wine and table grapes to protect and treat outbreaks of Botrytis cinerea as well as on apples to prevent post-harvest storage diseases, thereby helping to reduce food waste in the supply chain.  SumiAgro Europe has been appointed as the Company's exclusive distributor of Mevalone in the territory, with product distribution expected to commence imminently.

For further information, follow this link here.

To date, Eden has received regulatory approval in 17 US states for its formulated product Mevalone ®, and 8 US states for its formulated product Cedroz™. These approvals follow regulatory authorisation from the United States Environmental Protection Agency (EPA) in September 2022 for all six petitions submitted by Eden (three active ingredients, two formulated products and Eden's Sustaine ® polymer-free encapsulation technology; making up the building blocks of current and future products). 

For further information, please follow this link.